STAA
STAAR Surgical Company
STAA's fundamentals are strong, but it looks expensive: trading at 2678x earnings, about 20 times its usual 133x. Its downside scenario is more than ten times its upside.
STAA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
STAA's revenue, profitability, cash flow and balance sheet are all currently healthy.
STAA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 50x | $26.78 | — |
| Cheap | 82x | $0.82 | -97% |
| Fair | 132x | $1.32 | -95% |
| Expensive | 350x | $3.50 | -87% |
| Current | 2,678x | $26.78 | — |
Historical ranges are pointers, not guarantees.
STAA's PE is in its expensive range at 2678x. If earnings grow as analysts expect, today's price would be 50x next year's earnings, in its cheap range.
STAA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for STAA, with profitability holding steady. However, they disagree widely on these estimates.
STAA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.54 | +5306% |
| Q3 2026 | $0.01 | +$1.96 |
| Q2 2026 | $0.08 | +$2.01 |
| Q1 2026 | -$0.42 | +$1.02 |
| Q4 2025 | -$1.62 | -$1.21 |
| Q3 2025 | -$1.95 | -543% |
| Q2 2025 | -$1.93 | -668% |
| Q1 2025 | -$1.44 | -565% |
| Q4 2024 | -$0.41 | -195% |
STAA has returned to profit: it earned $0.01 per share over the past year, after losing money the year before.
STAA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $83.4M | -12% |
| Q2 2026 | $93.5M | +111% |
| Q1 2026 | $93.5M | +120% |
| Q4 2025 | $57.8M | +18% |
| Q3 2025 | $94.7M | +6.9% |
| Q2 2025 | $44.3M | -55% |
| Q1 2025 | $42.6M | -45% |
| Q4 2024 | $49M | -36% |
STAA's revenue is growing: $83M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.5% | -13 points |
| Q2 2026 | 11% | +78 points |
| Q1 2026 | 8.5% | +143 points |
| Q4 2025 | -40% | +18 points |
| Q3 2025 | 20% | +13 points |
| Q2 2025 | -68% | -80 points |
| Q1 2025 | -135% | -132 points |
| Q4 2024 | -57% | -71 points |
STAA's operating margin was 6.5% last quarter, down 13 points from the same quarter a year ago.
STAA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26.4M | +1379% |
| Q2 2026 | $19.2M | +$48.2M |
| Q1 2026 | -$22.1M | -$14.9M |
| Q4 2025 | -$5.6M | -$508K |
| Q3 2025 | $1.8M | +$4.2M |
| Q2 2025 | -$29M | -$12.4M |
| Q1 2025 | -$7.2M | -144% |
| Q4 2024 | -$5.1M | -118% |
STAA's free cash flow has turned positive after three years mostly in the red: $18M over the past year.
STAA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -52K shares |
| 1 year | +1.8% | +900K shares |
| 3 years | +4.2% | +2.1M shares |
| 5 years | +3.7% | +1.9M shares |
| Available history | +9.7% | +4.6M shares |
STAA has 51M diluted shares, up 1.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $2M |
STAA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -13.9x | Net Cash |
| Q2 2026 | -6.7x | Net Cash |
| Q3 2024 | -5.2x | Net Cash |
| Q2 2024 | -6.1x | Net Cash |
| Q1 2023 | -2.3x | Net Cash |
| Q4 2022 | -1.8x | Net Cash |
| Q3 2022 | -2.4x | Net Cash |
| Q2 2022 | -4.2x | Net Cash |
STAA has more cash than debt.
STAA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.9 | Neutral |
| Stochastic | 69.4 | Neutral |
STAA's weekly RSI is 58 (neutral) and its Stochastic is 69 (neutral).
STAA PE vs Healthcare Sector
| Metric | STAA | Sector median | Relative |
|---|---|---|---|
| PE | 2,678x | 26x | 10,260% above |
| PE % | 100 | 29 | 71 pts above |
STAA is trading at 2678x earnings, a 10260% premium to the Healthcare sector's median of 26x.
STAA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.1 | 16% above |
| 20 week MA | $23.9 | 12% above |
| 50 week MA | $23.7 | 13% above |
| 100 week MA | $22.8 | 18% above |
| 200 week MA | $33.3 | 19% below |
STAA has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 19% below its 200-week average.
STAA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $81.4 | +123% |
| 2021 | $81.4 | $96.3 | +18% |
| 2022 | $96.3 | $48.4 | -50% |
| 2023 | $48.4 | $31.2 | -36% |
| 2024 | $31.2 | $24.2 | -22% |
| 2025 | $24.2 | $23.4 | -3.6% |
| 2026 YTD | $23.4 | $26.8 | +15% |
STAA has finished four years in a row lower, and it's up 15% so far in 2026.